Wikidata

(Q61924901)

English

GEM05 for Patients With Multiple Myeloma More Than 65 Years Old

clinical trial

In more languages

Statements

title
A National, Open-Label, Multicenter, Randomized, Comparative Phase III Study of Induction Treatment With Melphalan/Prednisone/Velcade Versus Thalidomide / Prednisone / Velcade and Maintenance Treatment With Thalidomide / Velcade Versus Prednisone / Velcade in Untreated Patients With Multiple Myeloma More Than 65 Years Old. (English)
0 references
country
Spain
0 references
start time
March 2005
0 references
end time
March 2007
0 references
number of participants
260
0 references
research intervention
prednisone
0 references
melphalan
0 references
bortezomib
0 references
thalidomide
0 references
minimum age
66 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q61924901&oldid=2111719177"